Zuvotolimod

Modify Date: 2025-09-12 02:27:33

Use of Zuvotolimod

Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].

Name	Zuvotolimod

Description	Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Research Areas >> Inflammation/Immunology
References	[1]. Peter Armstrong Thompson, et al. Anti-liver cell or viral antigen antibody conjugate with myeloid cell agonist for treatment of hepatitis. Patent WO2019118884 A1. [2]. Sean Wesley Smith, et al. Preparation of benzazepines and their conjugates containing peptidyl linkers for the treatment of cancer and modulation of TLR8. Patent WO2020056194 A1.

Description

Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker

Research Areas >> Inflammation/Immunology

References

Molecular Formula	C₅₅H₇₀N₁₂O₁₀
Molecular Weight	1059.22

Get all suppliers and price by the below link: